State of New Jersey Common Pension Fund D - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,607,342
+14.6%
126,693
+161.8%
0.01%
+12.5%
Q2 2023$2,275,815
-1.4%
48,401
-12.0%
0.01%0.0%
Q1 2023$2,308,849
+1.0%
55,025
-8.2%
0.01%
-11.1%
Q4 2022$2,285,959
-2.6%
59,9360.0%0.01%0.0%
Q3 2022$2,347,000
+4.0%
59,936
-14.2%
0.01%0.0%
Q2 2022$2,256,000
-8.2%
69,834
-5.9%
0.01%
+12.5%
Q1 2022$2,457,000
-15.9%
74,242
+8.1%
0.01%0.0%
Q4 2021$2,921,000
+0.8%
68,671
+5.0%
0.01%
-11.1%
Q3 2021$2,898,000
+45.6%
65,396
+86.6%
0.01%
+28.6%
Q2 2021$1,991,000
-21.5%
35,042
+3.4%
0.01%
-22.2%
Q1 2021$2,537,000
-17.6%
33,895
-4.8%
0.01%
-18.2%
Q4 2020$3,079,000
+4.1%
35,591
-26.5%
0.01%
-8.3%
Q3 2020$2,959,000
+34.9%
48,421
-8.2%
0.01%
+33.3%
Q2 2020$2,193,000
+98.3%
52,743
+36.9%
0.01%
+80.0%
Q1 2020$1,106,000
-60.2%
38,5230.0%0.01%
-50.0%
Q4 2019$2,781,000
-50.6%
38,523
-3.9%
0.01%
-54.5%
Q3 2019$5,626,000
+104.9%
40,100
+167.3%
0.02%
+120.0%
Q2 2019$2,746,000
+15.1%
15,0000.0%0.01%
+11.1%
Q1 2019$2,386,000
+398.1%
15,000
+200.0%
0.01%
+350.0%
Q4 2018$479,000
-32.2%
5,0000.0%0.00%
-33.3%
Q3 2018$706,000
-9.8%
5,0000.0%0.00%0.0%
Q2 2018$783,000
-2.7%
5,0000.0%0.00%0.0%
Q1 2018$805,0005,0000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders